Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

World Bank Contributes Millions To New Indian Anti-Malaria Effort

This article was originally published in PharmAsia News

Executive Summary

The World Bank has earmarked $520.8 million to help India combat several fatal diseases, particularly malaria. The program is the body's largest such project and includes funds for treating more than 100 million Indians who, on average get malaria at the rate of more than 2 million a year. The funds also are to cover prevention services. The bank noted that falciparum malaria, an often-fatal severe form, has been on the rise in the country because of increased resistance to chloroquine, the primary malaria drug. The funds are intended to provide access to a new highly effective drug regimen for malaria. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC069258

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel